Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles. Chittasupho C*, Lirdprapamongkol K, Kewsuwan P, Sarisuta N. Eur J Pharm Biopharm. 2014 Oct;88(2):529-38.

01 Oct 2014
0

Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles.

Chittasupho C*, Lirdprapamongkol K, Kewsuwan P, Sarisuta N.

Eur J Pharm Biopharm. 2014 Oct;88(2):529-38.

Tags

Share this

Related Posts

Identification of new 3-phenyl-1H-indole-2-carbohydrazide derivatives and their structure-activity relationships as potent tubulin inhibitors and anticancer agents: A combined in silico, in vitro and synthetic study. Saruengkhanphasit R, Butkinaree C, Ornnork N, Lirdprapamongkol K, Niwetmarin W, Svasti J, Ruchirawat S, Eurtivong C*. Bioorg Chem. 2021 May;110:104795.

Recent Posts